Pharmacogenomics (PGx)

While genetics account for up to 90% of the variation in drug disposition and effects, the metabolic rate vastly varies between individuals. Classes run from poor to rapid metabolizers of drugs based on genotypes.

PGx, or Pharmacogenetic, testing services use the patient’s genes to determine disposition and response to combinations of drugs. This testing identifies possible sensitivities to drug effects and helps medical providers minimize or avoid risks in dosing associated with unknown reactions. This can potentially completely mitigate trial and error testing and adverse effects.

This simple, accurate test offers the potential to save lives. It has a short turnaround time (less than two weeks). The results are easily discernible for both physicians and patients alike, and will help eliminate physician guesswork while promoting patient safety.

This comprehensive panel report will help physicians rank medication options that best suit the patient’s effective dose and which medications they should avoid.

Who Should Consider This Test?

  • Patients with difficulty finding an effective dose in medication
  • Patients requiring abnormally high doses
  • Patients with expensive medications
  • Patients with a family history of ADR
  • Patients with multiple prescription medications
  • Patients introducing new prescriptions to their regimen
  • Patients taking a drug metabolized by the CYP450 enzyme
  • Patients taking drugs that inhibit or stimulate the CYP450 enzyme